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Abstract
On the development of nano-world, nanotechnology provides enormous oppor-
tunities in daily routine products and further future sustainable innovations. The
nanotechnology extends its benefits to various fields such as engineering, medical,
biological, environmental, and communication. However, the exponential growth
of nanomaterials production would lead to severe complications related to their
hazardous effects to the human health and environment. Moreover, negative
impact of nanomaterials toxicity on human health is one of the significant issues on
exhausting nano-products. The most vulnerable situation is associated with the use
of nanomaterials in the biomedical application. The several efforts have been ongo-
ing to study the nanotoxicity and its interaction with the biomolecules. Neverthe-
less, it is hard to assess and validate the nanotoxicity in a biological system. This
chapter aims to study the challenges in determining the toxicity of nanomaterials.
The toxicity assessment and hurdles in determining the impact on biological sys-
tems are epoch making. In-vitro, in-vivo, and in-silico studies are summarized in this
chapter in assessing the toxicity of engineered nanomaterials. The different
approaches of toxicity assessment have their difficulties faced by researchers while
characterizing nanomaterials in powder form, solution-based, and interacting with
biological systems. The assessment tools and characterization techniques play a vital
role in overcoming the challenges, while the cytotoxic assays involve nanoparticle
shape, morphology, and size consideration.
Keywords: nanotechnology, nanoparticles, characterization, in-vitro, in-vivo,
in-silico
1. Introduction
In today’s high-tech world, nanotechnology has become so much popular in
various fields due to its unique and beneficial physicochemical properties [1].
Some of the essential applications in multiple areas have been mentioned in Table 1.
Bringing the materials to nanoscale level helps in improving mechanical, optical and
electrical properties. It can be explained due to the increase in surface area to
volume ratio and hence, surface-related properties become more significant.
The small size and higher specific surface area of NMs furnishes the distinctive
properties and leads to unpredicted biological response on interaction with
biological system. Further, they also impart different biokinetic behavior and
capabilities to reach farther in body as compared with their larger counterparts.
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With the increasing use and production of nanomaterials (NMs), occupational
exposure is also growing. Other concern is related to environment and ecosystem
disturbance. Some of these apprehensions have forced scientist to investigate and
understand the potential adverse effects of engineered nanomaterials on health and
environment and also, explore the challenges to assess the toxicity of these mate-
rials. Several reports on toxicity assessment of NMs published in the last few
decades. However, still it is a challenging task to investigate the interactions of
nanoparticles (NPs) with biological systems. One of the probable reasons could be
due to experimental methods and precise characterization involving toxicological
assessment of NMs. Although, human health is at considerable risk because of
toxicity of these nanotechnology-based goods on exposure/intake by several routes
(Figure 1 and Table 2) [36].
Applications Usage Ref.
Nanomedicine Fluorescence and multiphoton bioimaging, in vitro diagnostics, in vivo
fluorescence imaging, drug delivery, photodynamic therapy,
Photothermal-controlled drug delivery and cancer treatment, drug
release, bioimaging, Tissue engineering, gene therapy, regenerative
medicine, MRI, magnetically guided control drug delivery,
magnetic biosensing, Drug release and gene delivery, gene
material and vaccines
[2]
Health sector Therapeutic targets in chemotherapy; bio-nanosensors; nanocoatings;
nanocarrier for vaccination; antimicrobial activities;
nanophotothermolysis for cancer, nanofilter, cosmetic products,
[3–6]
Food and
agriculture
Nanofertilizers, nanofungicides, nanopesticides, engineered
nanomaterials, CNT (carbon nanotube), nanoporous membrane,
food-based nanodelivery vehicles, food storage and packaging, functional
foods, bio-actives, nutraceutical systems, and pharma foods
[7–11]
Energy and
environment
Wastewater treatment, adsorption and degradation of organic/inorganic
pollutant, nanofilters/membranes, Solar energy, energy storage, H2
generation, Li-ion battery
[12–20]
Defense and
security
Smart materials, fuel additives, modern weapon, nanocoatings,
nanocomposites, night vision camera, sensors and electronics, and energy
devices, robotics
[21–24]
Automobile Nanomaterials in paints, nanocoatings, catalyst as additives, nano-based
lubricants, fuel cells, composite fillers, smart lights
[25–27]
Building Pigment in Interior and exterior paints, as a thin film on glass
windows, photocatalyst, adsorbent, as a membrane, hydrophilicity,
climate control, sensors, Rheological behavior under uniaxial extensional
flow, improved mechanical properties, fire retardant and insulation,
cement composite
[28]
Electronics
device
LED, OLED, nanotransitor, nano-based memory device, opto-magnetic,
spintronics, electrochromic device, nanogenerator
[29–31]
Textiles Smart fibers, stain repellence, wrinkle-freeness, nanocoatings, high
absorbency, softness and breathability, military applications
[32, 33]
Sports Nanofibers, ball coatings, CNT based sports items [34, 35]
Table 1.
List of numerous applications of nanomaterials in different area.
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Figure 1.
Exposure pathways of nanoparticles.
Nanomaterials Possible risks
Carbon, silver and
gold NPs
Affect the central nervous system, respiratory toxicity, liver toxicity
Carbon NPs Pulmonary inflammation, granulomas, and fibrosis, inhibition of DNA enzymes,
enhanced cytotoxicity, pulmonary toxicity
Cd-based
compounds
Nephrotoxic potential, cell and DNA damage, lungs and liver toxicity, fetus
malformation, hampered growth, enhanced cytotoxicity
CuO NPs Suppress immune system, cell and DNA damage, toxic to aquatic organisms
Ceria NPs Reactive Oxygen Species (ROS) production, decreased lifespan, cell membrane
and DNA damage, lipid peroxidation
TiO2 NPs Genotoxicity, metabolic change, neurotoxicity, skin penetration, cell damage,
ROS production, reproductive toxicity
ZnO NPs Hepatic oxidative stress, severe liver damage, reproductive toxicity on
earthworms
QDs (Quantum
Dots)
Lung infection and inflammation, fetus malformation, hampered growth, sperm
count and quality decreases, cell damage
SiO2 NPs Chronic obstructive pulmonary disease, tuberculosis. Lipid peroxidation and
membrane damage, mitochondrial dysfunction, lung cancer, cell death
(necrosis)
Nano-MOFs Reproductive and respiratory toxicity, immunotoxicity, neurotoxicity,
carcinogenicity
Table 2.
List of nanoparticles causes possible toxicity to the human body [2].
3
Challenges for Assessing Toxicity of Nanomaterials
DOI: http://dx.doi.org/10.5772/intechopen.89601
2. Challenges in characterization
To study the toxicity of any chemical substances, characterization of materials
plays a significant role. There are several techniques available these days which can
be used to characterize nanomaterials in powder form, film as well as in solution
and further its interaction with biomolecules can be studied (Figure 2). Although, it
becomes much more imperative and extensive in case of nanomaterials due to the
different shapes and sizes with variable surface area, charge and chemistry, crys-
tallinity, porosity, agglomeration, solubility, etc., (Figure 3). Further, the
nanomaterials generated from experiments must ensure reproducibility of
Figure 2.
Characterization of nanoparticles in different media [37].
Figure 3.
Challenges of characterization of nanoparticles.
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nanomaterials and thus higher reliability of the results. Characterization of
nanomaterials requires highly sophisticated instruments and skilled human
resources to study them. The precise properties of nanoparticles and their toxicity
details are poorly understood. Thus, a more wide-ranging and comprehensive
characterization, including size distribution, shape, surface area, surface chemistry,
crystallinity, porosity, agglomeration state, surface charge, solubility, etc., is
suggested for nanomaterials in order to determine the perfect connection between
their physicochemical properties and the biological effects they produce [37]. How-
ever, due to limited facilities in lab, scientists are bound to utilize the techniques
available to them. Therefore, characterization techniques plays crucial role in
experimental findings of nanomaterials.
On account of toxicity assessment, size is one of the crucial factors which alter
the functionality of nanomaterial along with diversified interaction with living
system. Size of nanoparticles can be determined by several techniques such as
Brunauer–Emmett–Teller (BET), dynamic light scattering (DLS) and transmission
electron microscopy (TEM). Nevertheless, further challenge is to find out accurate
average sizes and size distribution which are in fact different provided by different
methods. It is due to different principles involved in the several techniques. Addi-
tionally, measurement differences can also be explained based on sample prepara-
tion methods and instrument functioning procedures. However, this may generate
misperception to find out the correct nanoparticle size and size distribution; there-
fore, one has to be well competent in the principles and technical details of the
measurement methods involved. However, a deep understanding needed of NMs
toxicity and their interactions with biological system Figure 4.
3. Assessment of nanomaterial toxicity via in-vivo, in-vitro, and in-silico
approaches
The route followed by nanomaterials inside the organisms and their persistence
as well as their assimilation pathways determined with a deeper understanding of
the nature and interactions of NPs. There are numerous pathways to find out NPs
Figure 4.
Safe application of nanomaterials in therapeutics requires a deeper understanding of the material properties
and behaviors at different levels of biological organization; increasing insight necessitates cross-disciplinary
research collaborations (©2017 her majesty the queen in right of Canada. WIREs Nanomedicine and
Nanobiotechnology published by Wiley periodicals, Inc.) [38].
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route as well as their affirmative parameters inside the body of organisms. Broadly,
these analyses framed under in-vivo, in-vitro, and in-silico assessment (Table 3).
3.1 In-vitro methods
The in-vitro techniques for toxicity assessment are considered to be the most
reliable, cost-effective, wider applicability, a broad range of accessibility, and more
ethical due to animal fewer studies. The techniques based on the principle of
Technique Assessment details Instrumentation References
In-vitro • Selection of cell lines such as
phagocytes, hepatic, hematologic,
epithelial, and tumorous, etc.
• Cytotoxicity assays based on ROS
production, detection, and effector,
etc.
• Cell viability assays
• Cell stress assays such as gene
expression, an inflammatory
marker, cell visualization, etc.
• Disadvantages like lack of
secondary inferences of NMs and
unrevealed physiological pathways.
• Electron microscopy (SEM,
TEM, etc.)
• Optical spectroscopy
• Dynamic light scattering
[39–43]
In-vivo • Intracellular behavior of NMs is
different and may affect various
organs which mainly include:
hematological toxicity,
nephrotoxicity, hepatotoxicity,
pulmonary toxicity, and splenic
toxicity.
• Studies crucially dependent upon
size, surface charge, surface
coating, and shape of nanoparticles.
• Model living animals such as mice,
zebrafish, rodents, and non-human
primates
• Disadvantages include non-ethical
nature and a more extended
assessment period
• Electron and optical microscopy
• Magnetic resonance imaging
• Atomic force microscopy
[41, 44–47]
In-silico • Computational simulation and
assessment of the relationship
between physicochemical
properties and nanotoxicity
• Models illustrating nano-bio
interfaces
• Hazard control and risk assessment
of NMs.
• Development of High throughput
screening (HTS) data and
Quantitative structure–activity
relationship (QSAR) models.
• Generated data set depend upon
reliable experimental toxicity
results obtained through in vitro
and in vivo studies.
• Theoretical calculations and
computational simulations are
needed to generate reliable data
sets for comparative studies
[48–52]
Table 3.
Summarizes the assessment of nanomaterial toxicity via three different approaches in-vivo, in-vitro
and in-silico.
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mimicking cellular components and predicting results concerning the body of an
organism [53]. The reviews are extremely helpful in regulating the dosage limits and
fate of xenobiotic exposed. The different cell lines in a suitable environment
exposed to nanomaterials and after incubation, the proliferation and metabolism of
an exposed component are assessed with the help of different assays [54, 55].
However, physiological outcomes and prediction of results of xenobiotics are very
critical. Still, primary assessment follows in-vitro procedures because of minor
hurdles and easy availability.
Fast and comprehensive detection using in vitro technique (Figure 5) is proved
to be the most widely accepted methodologies and various assays used in cytotox-
icity investigation. The assays are different only in their mechanism of cell death
and detection methodology [53, 57].
3.2 Common assays for in-vitro toxicity assessment
3.2.1 MTT assay
Viable and non-viable cells due to their metabolic activities releases enzymes
which can further form complexes with dye molecules are the basis of colorimetric
determination of cytotoxicity caused by nanoparticles [58]. The cytotoxicity assess-
ment by analyzing the mitochondrial activity performed using MTT assay. MTT is
(3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium) cation (MTT+) an useful
redox indicator in pharmacology [59]. The colorimetric assay based on metabolic
activities of viable cells [60]. Along with mitochondrial activity, MTT assay also
applicable to non-mitochondrial enzymes and endosomes, etc. The MTT tetrazo-
lium salt crosses the membrane of active cells and reduces to formazan (1-[4,5-
dimethylthiazol-2-yl]-3,5-diphenylformazan) which is a purple-colored product.
The colored solution further analyzed with the help of spectrophotometry.
Figure 5.
Validated in-vitro techniques used [56].
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The color intensity is proportional to the concentration of living cells; hence, the
quantitative determination of viable cells can be completed with the help of this
assay [61]. Further modification of this test leads to formation of tetrazolium
derivatives such as 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bro-
mide (MTT), salt (WST-1), 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-
(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt (WST-8) which form water-
soluble formazan while interacting with cells [62–64]. However, the reports show
some unmatched results such as more viable cell count even at high exposure of
toxic nanomaterials. Braun et al. [61] reported the overestimation of cytotoxicity at
a moderate concentration of mesoporous silica nanoparticles with MTT assay when
compared with ATP based assay.
3.2.2 LDH leakage assay
Lactate dehydrogenase (LDH) is a cytosolic enzyme present in all living cells.
When a breakdown of the cellular membrane occurs due to nanoparticle toxicity,
LDH oozes out to extracellular space where it can indicate the cytotoxicity. The free
LDH in extracellular space catalyzes the interconversion of pyruvate to lactase and
β-nicotinamide adenine dinucleotide (NADH) to NAD+. Since NADH has absor-
bance at 340 nm, the concentration of LDH level can be determined by decreased
concentration of known initial concentration of NADH and lactate [65]. Also,
enzyme diaphorase utilizes NADH and H+ for catalyzing the reductive conversion
of tetrazolium salt to a highly colored formazan salt which can be measured spec-
trophotometrically. Wang et al. [66] reported the LDH assay for cytotoxicity deter-
mination of single-walled carbon nanotubes (SWCNTs) and oxidized SWCNTs.
The formazan concentration decreases with increasing concentration of SWCNTs
elucidated from spectrophotometric determination, where absorbance at 490 nm.
Each cell type has specific LDH pool and passage; therefore, test measurements
were first standardized with purified LDH and then LDH derived from lysed DH-82
cells were tested. Nanoparticle toxicity can affect the activity of LDH by dynamic
adsorption of LDH on nanoparticle surface leading to inactivation. Also, NPs
can generate free radicals or metal catalyzed oxidation processes for inactivation
of LDH.
3.2.3 Trypan blue dye +assay
Trypan is an azo dye and used to stain non-viable cells and used in the cytotoxic
assessment. The viable cell resists uptake of trypan and cytoplasm of these cells
remain unaffected while trypan treated non-viable cells show blue cytoplasm and
colorimetric determination of these cells possible.
3.2.4 Apoptosis assay
Apoptosis is programmed cell death and categorized under type-I cell death. The
cell death controlled by various type of cell signals, where, a sudden stop of these
signals triggers cell death. The apoptosis activation starts the initiation of extracel-
lular proteases called caspases. These proteases further initiate activities leading to
cell death. Apoptosis is characterized by condensation of chromatin and nucleus as
well as DNA fragmentation. There are various assays for determining apoptosis
such as TUNEL, Lamina-B, and, Apostain techniques. TUNEL is terminal
deoxynucleotidyl transferase dUTP nick end labeling technique which detects the
fragments of DNA which produce in the final step of apoptosis. Mechanism of the
TUNEL technique involves the fluorescent dye coupling with dUTP nucleotide
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present in assay, which further fastens with fragmented DNA. The quantitative
analysis with the help of fluorescent microscopy or immunohistochemical staining
can be done. Despite being a cost-effective and smooth operation of this technique,
this technique does not distinguish necrosis and apoptosis while observing only the
end stage result of the process. Apostain technique is associated with early detection
of caspase-3 in the cytoplasm and does not rely on fragments of DNA. Hence, this
technique is useful in early detection where activation of apoptosis and release of
specific protease lead to brown coloration, and healthy cells remain blue when
observed under the light microscope. This technique is particular, sensitive, and
remains one of the most used methods in apoptosis analysis. Unlike apostain,
Lamina-B is also an early-stage assessment technique. The nuclear lamina is the
structures responsible for DNA replication, even for the reorganization of chroma-
tin, and present in nuclear membrane. This lamina is of two type lemin-A (acidic or
neutral) and lemin-B (neutral). The release of caspase 6 during apoptosis leads to
lemin cleavage, which further triggers the chromatin condensation. Immunohisto-
chemistry antigens markers are used to identify lemin-B.
3.2.5 20, 70-dichlorofluorescein diacetate (DCFH-DA) assay
Reactive oxidative species (ROS)induces the oxidative stress to the living cells
due to internalization. The Injured cells membrane is porous for entry of non-polar
dye 2,7-dichlorofluorescin diacetate (DCFH-DA) and converts into non-fluorescent
DCFH due to hydrolyzation of intracellular esterase. The DCFH oxidized to fluo-
rescent dichlorofluorescein in the presence of ROS. Thus, the quantification of ROS
can be measured with fluorescence intensity measurements.
3.2.6 Comet assay
This assay named after its visual appearance, which looks like a comet, consist of
single-cell gel electrophoresis technique (SCGE). This assay is widely used in vitro
analysis technique, which is most reliable and inexpensive. The DNA damage during
nanoparticle toxicity analyzed in this technique, whereas negatively charged DNA
fragments separated using gel electrophoresis. Cells with toxicity encapsulated in
agarose gel further lysed with salts and detergents which digest cytoplasm and other
cell components except for nucleoids. Further electrophoresis at high pH results into
a comet-like structure where the head of the comet represents intact DNA and tail
comprises of the fragmented portion. Hence, the fluorescent marking and intensity
of the tail show the damaged part of DNA leading to the estimation of toxicity.
3.3 In-vivo methods
These methods retain their most favorable and primary standards for assessment
of toxicity. These studies based on the use of living animal, which is considered a
little less ethical. The mode of in vivo studies involves the administration of
nanomaterial into the body of testing animal and monitoring the signs of progress
through different techniques. Since this procedure requires real-time analysis, and
result obtained are more coherent with human body functioning, minimizing the
impact of time and cost.
The in-vivo results for toxicity assessment are different from in vitro counter-
parts because of various crucial factors, which cannot involve in in-vitro assessment.
The impact of hormonal changes, cell–cell and cell-matrix interactions add on
in-vivo assessment. The long-term chronic effects are not possible in-vitro studies;
hence, some impacts are missing during in-vitro analysis. The in vivo studies,
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however, carried out with more considerable precautions because they are inter-
laced with many challenges. In-vivo dose is determined based on actual exposure of
nanomaterial to the body, which is a technical challenge because of minimal size
and peculiar properties in the biological system. During in-vivo experiments, the
vehicle to carry out nanoparticle dose must be non-reactive, and NPs must disperse
appropriately in it. Since NPs are very susceptible to agglomeration due to their
larger surface area. Agglomeration and poor dispersion lead to improper biological
distribution and unwanted results. Once the nanomaterial inside the body, they can
interact with protein counterpart leading to the formation of the protein corona.
These lead to alteration in the properties of NPs, their interaction, and
biodistribution. Protein structure further undergoes conformational changes and
leads to modified biological functions as well as altered signaling pathways. Hence
before assessing the toxicity of NPs in a biological system, one must also consider
the various interferences of NPs with another substrate [67].
Chen et al. [68] investigated gold nanoparticles (AuNPs) of size 21 nm on male
C57BL/6 mice by collecting the tissues after 1, 24, and 72 h post injecting the 7.85 μg
AuNPs/g solution of AuNPs. Further analysis was done using Scanning Electron
Microscopy (SEM) and proinflammatory cytokine expression, as well as macro-
phage counting, was done with real-time PCR. The results show the compatible
nature of AuNPs with living tissues and not observed a significant change in the
number of macrophages. However, the reported results show an accumulation of
AuNPs in abdominal fat, and some quantity also found in the liver, leading to a
reduction of fat in AuNPs treated mice. Rizzo et al. [69] used zebrafish embryo for
correlating the results obtained from in vitro analysis with in vivo studies. Authors
used different NMs for toxicity assessment both in vitro assays. The coating on
nanomaterials with biocompatible polymers shows a significant decrease in the
toxicity. The results for pristine ultra-small superparamagnetic iron oxide (USPIO)
and flavin mononucleotide coated USPIO (FLUSPIO) and sineram tested in vitro on
HeLa (human cervical carcinoma), HUVEC (human umbilical vein endothelial)
and SMC (ovine smooth muscle) and in vivo studies carried out on zebrafish
embryo assay. The in vitro studies do not show any cytotoxic effect on different cell
lines up to concentration 10 mg/mL, on the other hand in vivo studies for toxicity
analysis on zebrafish embryo assay show different results as compare with in vivo.
The similar dose of NP causes lethal effect on embryo. The toxicity of pristine
USPIO greater than coated counterparts, FLUSPIO and sineram. Even the lethal
effect not observed for coated nanoparticles at high exposure time up to 72 and
168 h. The probable reason for cytotoxic effects given by authors was aggregation of
uncoated nanoparticles and further due to larger hydrodynamic size lead to block-
age of egg chorion pores [70]. In another study based on zebrafish embryo shows
stage-dependent toxicity and specific phenotype with AgNPs (97  13 nm). Differ-
ent developmental stages of embryos have different critical concentration of
nanoparticles such as Cleavage stage (3.5pM), Gastrula stage (4pM), Segmentation
stage (6pM), Hatching stage (8pM) [71]. The maximum number of abnormalities
found in deformed zebrafish developed from cleavage and gastrula stage of
embryos. However, the later stages do not show significant deformities. The early-
stage embryos show head and eyes deformities which are not present in later-stage
embryos. The cleavage stage and gastrula stage abnormalities are more prominent
and also increases with increase in concentration of AgNPs owing to their impact on
early determinative events like cell signaling and gene transcription. The AgNPs
stays inside embryos throughout their development. The longitudinal thin layer
sections with all deformities shown in Figure 6. The observed NPs found embedded
in eye, pericardial space, and in tail which are characterized by LSPR spectra of
individual AgNPs.
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3.4 In-silico assay
Considering the time requirement, ethical standards, and reliable results, scien-
tist prompted to use alternative ways for analyzing the toxicity of materials. The in-
silico analysis one of the novel approaches as compared with general studies. The
procedure is based on the principle of theoretical modeling and simulation of results
for various physicochemical properties of molecules (Figure 7). The available data
Figure 6.
Imaging and characterization of individual Ag NPs embedded in the tissues of (a  C) deformed zebrafish and
(D  F) normal zebrafish (control) using DFOMS-MSIS. Optical image of thin-layer longitudinal section of
fixed (a) deformed zebrafish with five types of deformities and (D) normal zebrafish. (C) and (F) zoom-in
optical images of the tissue sections of (a  c) as highlighted in (a) and (D), respectively: (a) eye (retina),
(b) pericardial space, and (c) tail. (B) LSPR spectra of individual Ag NPs as circled in (C) show distinctive
λmax (fwhm): (a) 567 (176), (b) 688 (185), and (c) 759 (179) nm. (E) Scattering intensity of the tissues
of normal zebrafish in (F) shows the background (nondistinctive plasmonic colors). Scale bars in (a) and
(D) are 250 μm and in (C) and (F) are 5 and 30 μm, respectively. “Reprinted with permission from [71]
(2013) American Chemical Society.
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of toxicity of material and their interpolation using multiple mathematical models,
in silico studies owes many advantages still there are limitations because experi-
mental verification needed additionally to prove the toxicological effects. Also, due
to the data gap, the quantitative risk assessment of nanomaterials on web-based
tools has not much explored. Current methodologies based on exposure assessment
in production and manufacturing life stages while ignoring the exposure during use
and end stages of the life cycle of nanomaterials. Based on physicochemical proper-
ties and their descriptions, computational chemistry methods has been modified to
nano-based models such as nano quantitative structure–activity relationship (nano-
QSAR) or quantitative nanostructure activity relationship (QNAR) [73].
In-silico methodology selects the models that have historical development or
represent state-of-the-art methods for assessment of toxicity. Structural alerts and
rule-based models are used for evaluation of toxicity. The structural alerts are
chemical structures representing the toxicity while rule-based models are derived
either from human knowledge and literature (Human-based Rules) or from com-
putational simulations of data (Induction-based Rules), which rely on probabilities
[72, 74].
Two European projects named GUIDEnano tools and SUN Decision Support
System (SUNDS) provides valuable information about the implementation of tools
for assessment of nano-enabled products in their whole life cycle [75, 76]. These
web-based tools create a sustainable portfolio for production, handling, and end
cycles of engineered nanomaterials. It also needs the exploited data about physico-
chemical, toxicological, and exposure of nanomaterials. Life cycle analysis approach
critically required for assessing the impact of nanomaterials on the environment.
The collection of data, transfer, and transformations of nanomaterials, Leading to
toxicological effects to humans and environment can be predicted through risk
assessment tools.
The above-discussed assays, however, experience production of erroneous
results due to interference arising due to NPs solubility, agglomeration, particle
sedimentation, and, the formation of the protein corona. The problem can be
Figure 7.
In-silico toxicology tools, steps to generate prediction models, and categories of prediction models (copyright ©
2016 the authors. WIREs computational molecular science published by John Wiley & Sons, Ltd. [73]).
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appropriately acknowledged by designing and establishing a standard set of essays
which need to be following particular nanotoxicological standards and uniform
applicability. The generation of standardized protocol further faces the challenge of
different nature of nanomaterials to be assessed since metallic NPs, and carbon-
based nanotubes have different physicochemical characteristics in physiological
conditions. The metallic NPs and CNTs show different physical traits at nano-
cellular interface leading to altering the biological response. CNTs and metallic NPs
both produce ROS species but follows different pathways where metal NMs causes
apoptosis, while CNT leads to fibrosis and inflammation [77]. CNTs and metallic
NPs are also different in their assimilation pathways in the biological system. CNTs
found to be less biodegradable and persisting in system for a longer duration while,
metallic NPs undergo dissolution into ions further disrupting the biological path-
ways [78, 79].
3.5 Physicochemical parameters for toxicity assessment
Cellular responses are directly linked to physicochemical parameters of
nanomaterials. The advancement in material science has achieved a precise synthe-
sis of nanomaterials with adjustable target and specific action. There are various
morphological factors on which nanotoxicological response depend such as size,
surface morphology, charge and, composition, etc.
3.5.1 Size of NMs
Size of the NMs are a primary factor for determination of cytotoxic response.
It affects the internalization process into cells and endocytosis process, which ulti-
mately altering the intracellular fate of nanomaterials. Most of the studies conclude
that smaller the size of NPs, higher the degree of cytotoxicity [80, 81]. Bharadwaj
et al. [82] reported the assessment of variable sized nanoparticles ranging from 20
to 500 nm in processed brain tissue sections with the help of confocal microscopy.
Maximum accumulation was observed for 1 hour and it was found that 500 nm
particles accumulated the most. However, NPs shows selective accumulation
behavior. In the case of quantum dots (QDs), the cytotoxicity and size depend upon
the method of preparation. QDs produced by using ligands like trioctylphosphine
lead to hydrophobic nature and further converted to hydrophilic, leading to an
increase in hydrodynamic radius of NMs [83].
3.5.2 Surface
Cellular uptake mechanism and cytotoxicity relies on the morphology of NPs.
NMs have different kind of shapes, which includes spheres, needles, cubes, tubes,
rods, etc. Membrane interactions during internalization of NPs affect the nature of
barriers. Researchers reported the formation of pores in cell membranes due to
interactions of NPs, leading to an imbalance in an ionic concentration outside and
inside of the cell [84]. Chithrani et al. [85] reported the effect of size and shape of
AuNPs in internalization and concluded that when morphology changes from rod
shape to spherical, there is an increase in uptake up to 500%. Recently, Maysinger
et al. [86] also studied the gold nanourchins whose surface morphology has an
irregular shape. The functionalization with polyethylene glycol (PEG) on AuNPs
did not show any significant alteration in viability and morphology while cetyltri-
methylammonium bromide (CTAB) modification showed adverse effects on
filamentous actin and, nuclear lamina.
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3.5.3 Surface coating and charge on NMs
Surface coating on the nanoparticles surface act as a connecting link between
nano-cellular interfaces. Coating affects the interparticle interactions, cellular con-
tacts, internalization, and cytotoxicity of material [87]. Surface coating possesses
distinct charges which can alter the cytotoxicity of materials. Various studies show
that positively charged NMs internalized more effectively and also result in more
toxic effects than neutral or with negatively charged particles [88, 89]. Coatings
broadly divided based on interactions into three types by Richards et al. [90]. These
are covalent coatings having covalent bonding, the electrostatic surface coating
having electrostatic interactions, and atomic layer deposition where chemical bond
formed between molecule and coating material. Coating plays a crucial role in
various nanomaterial application in drug delivery, imaging, and cancer treatment
[91, 92]. Coating of chitosan reduces the production of ROS species in different
CuNPs and Fe2O3 NPs and reduces the inflammatory response and overall toxicity
of nanomaterials [93, 94]. Yin et al. [95] studied nickel ferrite NPs and explained
their toxicity through their surface coating with oleic acid. The toxicity with coated
nickel ferrite NPs depends upon the dose of material. The coating also shows
significant effects when changed from single layer to double layer by changing
hydrophobic and hydrophilic, respectively. It was observed that hydrophobic coat-
ing impart a high level of toxicity than the hydrophilic counterpart. Nanomaterials
are internalized through lipid bilayer membrane structure where the charge on the
membrane is negative. Hence, opposite charged NPs pass through effectively due to
electrostatic interactions while negatively charged bound less efficiently. The acid
treatment of carbon nanotubes (CNTs) leads to high toxicity due to surface
functionalization. The negative charge introduced due to hydroxyl (▬OH) and
carboxylic acid (▬COOH) contribute to more toxicity [96].
4. Future prospective and conclusion remarks
Nanotechnology exhibit excellent potential in developing new materials every
day; hence, nanomaterial safety also deserves much attention for their safer use.
Therefore, understanding the environmental fate and biological impact is highly
desired for designing biocompatible materials in place of abandoning
nanomaterials. There are numerous techniques to date for analyzing the toxicity
caused by nanomaterials. Still, diversified nanoparticles, different behavioral
impacts and variegate incubation protocols have rendered it and impossible to draw
the conclusion regarding toxicity. Nanotoxicity assessment broadly carried out in
two concerning fields; biological and environmental. The environmental factors
such as temperature, ionic strength and transformation of NMs inside biological
system regulate the toxicity. The properties of agglomeration, physicochemical
changes, and nano-bio interface interactions needs pharmacokinetic studies of
NMs. Most of the studies carried out with pristine NPs for toxicity assessment;
however, product or degradation product of NMs enter into environment and
should be encountered instead of pristine NMs. The transformed or degraded
materials in environment remain major challenge toward assessing toxicity specially
in case of carbon-based nanomaterials on biological substrates.
Biological fate of nanoparticle toxicity is the second major field where high-
quality instrumentation, sophisticated culture medium, and reliable in vitro and
in vivo assays are needed. Many recent studies accentuate in the present perspective
and put forward some model system to address the critical issues and dealing with
the impediment of assessment of nanotoxicity. Apart from standard viability tests,
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other parameters need to be considered such as intracellular stability, degradation
potential, and excretion pathways. There is a dire need for collaborative approach
and multidisciplinary aspect to analyze the broad field of NPs and cell interactions.
The major challenge in intracellular molecular events where relationship among
biological functions need to be addressed. The recent development in assessment of
toxicity include the adverse outcome pathways that include more proficient, pre-
dictive mechanistically approaches. This conceptual framework links the biological
event with molecular initiating event at earlier stages [97]. Advanced electroana-
lytical methods can be used to monitor these events and play determinant role in
assessment. In silico approach for nanotoxicity determination has also emerged out
as an alternative to in vivo and in vitro analysis. The computational simulation of
data, however, relies on experimental findings but more ethical mean for toxicity
assessment. The characterization of nanomaterials plays substantial role in compu-
tation of engineered NMs along with establishing the relationship between biologi-
cal activity and nanostructure [98]. Hence, programmatically executed reliable
experimental data can be utilized to predict the nanotoxicity before their manufac-
ture and use. In upcoming decade, Qiu et al. [99] presumed four basic predictive
models for nanomaterial properties and biological effects. These analytical chal-
lenges include nanotoxicological mechanism changed from correlative to causative
aspect, to conquer nanoparticle interferences for explicit in vitro analysis,
establishing single-cell level cellular response for nanoparticle interaction, and
understanding kinetic parameters of nano-bio interfaces.
Author details
Akanksha Gupta1, Sanjay Kumar2 and Vinod Kumar3*
1 Department of Chemistry, Sri Venkateswara College, University of Delhi, India
2 Department of Chemistry, Deshbandhu College, University of Delhi, India
3 Department of Chemistry, Kirori Mal College, University of Delhi, India
*Address all correspondence to: vinod7674@gmail.com; vinodkumar@kmc.du.ac.in
© 2019 TheAuthor(s). Licensee IntechOpen. This chapter is distributed under the terms
of theCreativeCommonsAttribution License (http://creativecommons.org/licenses/
by/3.0),which permits unrestricted use, distribution, and reproduction in anymedium,
provided the original work is properly cited.
15
Challenges for Assessing Toxicity of Nanomaterials
DOI: http://dx.doi.org/10.5772/intechopen.89601
References
[1]Dutta J. Nanotechnology in the
Developing World: 2015
[2] Kumar V et al. Nanotechnology:
Nanomedicine, nanotoxicity and future
challenges. Nanoscience &
Nanotechnology. 2019;9(1):64-78
[3] Parhizkar M et al. Latest
developments in innovative
manufacturing to combine
nanotechnology with healthcare.
Nanomedicine. 2018;13(1):5-8
[4] Vance ME et al. Nanotechnology in
the real world: Redeveloping the
nanomaterial consumer products
inventory. Beilstein Journal of
Nanotechnology. 2015;6(1):1769-1780
[5] Koopaei NN, Abdollahi M.
Opportunities and obstacles to the
development of nanopharmaceuticals
for human use. BioMed Central. 2016;
23:24(1-6). Available from: https://doi.
org/10.1186/s40199-016-0163-8
[6] Carvalho IT, Estevinho BN, Santos L.
Application of microencapsulated
essential oils in cosmetic and personal
healthcare products–a review.
International Journal of Cosmetic
Science. 2016;38(2):109-119
[7]He X, Hwang H-M. Nanotechnology
in food science: Functionality,
applicability, and safety assessment.
Journal of Food and Drug Analysis.
2016;24(4):671-681
[8] Singh H. Nanotechnology
applications in functional foods;
opportunities and challenges.
Preventive Nutrition and Food Science.
2016;21(1):1
[9] Yu H et al. An overview of
nanotechnology in food science:
Preparative methods, practical
applications, and safety. Journal of
Chemistry. 2018;2018:5427978
[10] Cerqueira MA, Vicente AA,
Pastrana LM. Nanotechnology in food
packaging: Opportunities and
challenges. In: Nanomaterials for Food
Packaging. Elsevier; 2018. pp. 1-11
[11] Sundarraj AA. Nano-agriculture in
the food industry. In: Plant Nanobionics.
Springer; 2019. pp. 183-200
[12]Dasgupta N, Ranjan S, Lichtfouse E.
Environmental Nanotechnology. Vol. 1.
Springer; 2018
[13] Andrews D, Nann T, Lipson RH.
Comprehensive Nanoscience and
Nanotechnology. Academic Press; 2019
[14]Hess DJ, Lamprou A.
Nanotechnology and the environment.
In: Nanotechnology and Global
Sustainability. CRC Press; 2018.
pp. 50-73
[15]Ahmadi MH et al. Renewable energy
harvesting with the application of
nanotechnology: A review. International
Journal of Energy Research. 2019;43(4):
1387-1410
[16] Ramsden J. Applied
Nanotechnology: The Conversion of
Research Results to Products. William
Andrew; 2018
[17] Kumar V et al. Facile synthesis of
Ce–doped SnO2 nanoparticles: A
promising Photocatalyst for hydrogen
evolution and dyes degradation.
ChemistrySelect. 2019;4(13):3722-3729
[18] Kumar V et al. Novel lithium-
containing honeycomb structures.
Inorganic Chemistry. 2012;51(20):
10471-10473
[19] Kumar V, Govind A, Nagarajan R.
Optical and photocatalytic properties of
heavily F–-doped SnO2 nanocrystals by
a novel single-source precursor
16
Biochemical Toxicology - Heavy Metals and Nanomaterials
approach. Inorganic Chemistry. 2011;
50(12):5637-5645
[20] Kumar V, Uma S. Investigation of
cation (Sn2+) and anion (N3)
substitution in favor of visible light
photocatalytic activity in the layered
perovskite K2La2Ti3O10. Journal of
Hazardous Materials. 2011;189(1–2):
502-508
[21] Petkov P et al. Advanced
Nanotechnologies for Detection and
Defence against CBRN Agents.
Springer; 2018
[22] Johny J et al. Waveguide-based
machine readable fluorescence security
feature for border control and security
applications. In: Counterterrorism,
Crime Fighting, Forensics, and
Surveillance Technologies II.
International Society for Optics and
Photonics; 2018
[23] Burmaoglu S, Saritas O, Yalcin H.
Defense 4.0: Internet of things in
military. In: Emerging Technologies for
Economic Development. Springer; 2019.
pp. 303-320
[24]Mulhall D. Our Molecular Future:
How Nanotechnology, Robotics,
Genetics and Artificial Intelligence Will
Transfor M our World. Prometheus
Books; 2010
[25]Werner M, Wondrak W,
Johnston C. Nanotechnology and
transport: Applications in the
automotive industry. In: Nanoscience
and Nanotechnology: Advances and
Developments in Nano-Sized
Materials. Walter de Gruyter GmbH;
2018. p. 260
[26]Mathew J, Joy J, George SC. Potential
applications of nanotechnology in
transportation: A review. Journal of King
Saud University. 2018;31:586-594
[27] Banerjee B. Rubber Nanocomposites
and Nanotextiles: Perspectives in
Automobile Technologies. Walter de
Gruyter GmbH & Co KG; 2019
[28] Sobolev K et al. Nanomaterials
and nanotechnology for high-
performance cement composites. In:
Proceedings of ACI Session on
Nanotechnology of Concrete: Recent
Developments and Future Perspectives.
Pennsylvania State University, USA;
2006. pp. 91-118
[29]Deleonibus S. Electronic Devices
Architectures for the NANO-CMOS Era.
CRC Press; 2019
[30] Verma A, Urbani F, Stollberg DW.
Electronic device with microfilm
antenna and related methods, Google
Patents: 2018
[31] Yuan H et al. Flexible electronic
skins based on piezoelectric
nanogenerators and piezotronics. Nano
Energy. 2019;59:84-90
[32] Yetisen AK et al. Nanotechnology in
textiles. ACS Nano. 2016;10(3):
3042-3068
[33] Afroj S et al. Engineering graphene
flakes for wearable textile sensors via
highly scalable and ultrafast yarn dyeing
technique. ACS Nano. 2019;13(4):
3847-3857
[34] Subic A. Materials in
Sports Equipment. Woodhead
Publishing; 2019
[35]Harifi T, Montazer M. Application
of nanotechnology in sports clothing
and flooring for enhanced sport
activities, performance, efficiency and
comfort: A review. Journal of Industrial
Textiles. 2017;46(5):1147-1169
[36]Warheit DB, Sayes CM. Routes of
exposure to nanoparticles: Hazard tests
related to portal entries. In:
Nanoengineering. Elsevier; 2015.
pp. 41-54
17
Challenges for Assessing Toxicity of Nanomaterials
DOI: http://dx.doi.org/10.5772/intechopen.89601
[37] Ribeiro A et al. Challenges on the
toxicological predictions of engineered
nanoparticles. NanoImpact. 2017;8:59-72
[38]Halappanavar S et al. Promise and
peril in nanomedicine: The challenges
and needs for integrated systems
biology approaches to define health risk.
Wiley Interdisciplinary Reviews:
Nanomedicine and Nanobiotechnology.
2018;10(1):e1465
[39] Cohen JM, DeLoid GM,
Demokritou P. A critical review of
in vitro dosimetry for engineered
nanomaterials. Nanomedicine. 2015;
10(19):3015-3032
[40]Hillegass JM et al. Assessing
nanotoxicity in cells in vitro. Wiley
Interdisciplinary Reviews:
Nanomedicine and Nanobiotechnology.
2010;2(3):219-231
[41] Ajdary M et al. Health concerns of
various nanoparticles: A review of their
in vitro and in vivo toxicity.
Nanomaterials. 2018;8(9):634
[42] Jones CF, Grainger DW. In vitro
assessments of nanomaterial toxicity.
Advanced Drug Delivery Reviews.
2009;61(6):438-456
[43] Arora S, Rajwade JM, Paknikar KM.
Nanotoxicology and in vitro studies:
The need of the hour. Toxicology and
Applied Pharmacology. 2012;258(2):
151-165
[44] Aillon KL et al. Effects of
nanomaterial physicochemical
properties on in vivo toxicity. Advanced
Drug Delivery Reviews. 2009;61(6):
457-466
[45]Menard A, Drobne D, Jemec A.
Ecotoxicity of nanosized TiO2. Review
of in vivo data. Environmental
Pollution. 2011;159(3):677-684
[46] Zhu X et al. Developmental toxicity
in zebrafish (Danio rerio) embryos after
exposure to manufactured
nanomaterials: Buckminsterfullerene
aggregates (nC60) and fullerol.
Environmental Toxicology and
Chemistry. 2007;26(5):976-979
[47] Ema M, Gamo M, Honda K. A
review of toxicity studies on graphene-
based nanomaterials in laboratory
animals. Regulatory Toxicology and
Pharmacology. 2017;85:7-24
[48] Landvik NE et al. Criteria for
grouping of manufactured
nanomaterials to facilitate hazard and
risk assessment, a systematic review of
expert opinions. Regulatory
Toxicology and Pharmacology. 2018;95:
270-279
[49] Basei G et al. Making use of
available and emerging data to predict
the hazards of engineered nanomaterials
by means of in silico tools: A critical
review. NanoImpact. 2019;13:76-99
[50]Oksel C et al. SAR modelling of
nanomaterial toxicity: A critical review.
Particuology. 2015;21:1-19
[51]Oksel C et al. Literature review of
(Q) SAR modelling of nanomaterial
toxicity. In: Modelling the Toxicity of
Nanoparticles. Springer; 2017.
pp. 103-142
[52] Sizochenko N et al. In silico methods
for nanotoxicity evaluation:
Opportunities and challenges. In:
Nanotoxicology. CRC Press; 2018.
pp. 527-557
[53] Fard JK, Jafari S, Eghbal MA.
A review of molecular mechanisms
involved in toxicity of nanoparticles.
Advanced Pharmaceutical Bulletin.
2015;5(4):447
[54] León-Silva S, Fernández-
Luqueño F, López-Valdez F. Silver
nanoparticles (AgNP) in the
environment: a review of potential risks
on human and environmental health.
18
Biochemical Toxicology - Heavy Metals and Nanomaterials
Water. Water, Air, & Soil Pollution.
2016;227(9):306
[55] Liu R et al. Evaluation of toxicity
ranking for metal oxide nanoparticles
via an in vitro dosimetry model. ACS
Nano. 2015;9(9):9303-9313
[56] Raj S et al. Nanotechnology in
cosmetics: Opportunities and
challenges. Journal of Pharmacy &
Bioallied Sciences. 2012;4(3):186
[57] Fotakis G, Timbrell JA. In vitro
cytotoxicity assays: Comparison of
LDH, neutral red, MTT and protein
assay in hepatoma cell lines following
exposure to cadmium chloride.
Toxicology Letters. 2006;160(2):171-177
[58] Bahadar H et al. Toxicity of
nanoparticles and an overview of
current experimental models. Iranian
Biomedical Journal. 2016;20(1):1
[59] Lison D et al. Nominal and effective
dosimetry of silica nanoparticles in
cytotoxicity assays. Toxicological
Sciences. 2008;104(1):155-162
[60]Hussain S et al. In vitro toxicity of
nanoparticles in BRL 3A rat liver cells.
Toxicology In Vitro. 2005;19(7):975-983
[61] Braun K et al. Comparison of
different cytotoxicity assays for in vitro
evaluation of mesoporous silica
nanoparticles. Toxicology In Vitro.
2018;52:214-221
[62] Almutary A, Sanderson B. The MTT
and crystal violet assays: Potential
confounders in nanoparticle toxicity
testing. International Journal of
Toxicology. 2016;35(4):454-462
[63] Jiang Q et al. Combined effects of
low levels of palmitate on toxicity of
ZnO nanoparticles to THP-1
macrophages. Environmental
Toxicology and Pharmacology. 2016;48:
103-109
[64] Chng ELK, Pumera M. Toxicity of
graphene related materials and
transition metal dichalcogenides. RSC
Advances. 2015;5(4):3074-3080
[65]Han X et al. Validation of an LDH
assay for assessing nanoparticle toxicity.
Toxicology. 2011;287(1):99-104
[66]Wang J et al. Oxygen vacancy
induced band-gap narrowing and
enhanced visible light Photocatalytic
activity of ZnO. ACS Applied Materials
& Interfaces. 2012;4(8):4024-4030
[67] Guadagnini R et al. Toxicity
screenings of nanomaterials: Challenges
due to interference with assay processes
and components of classic in vitro tests.
Nanotoxicology. 2015;9(sup1):13-24
[68] Chen H et al. In vivo study of
spherical gold nanoparticles:
Inflammatory effects and distribution in
mice. PLoS One. 2013;8(2):e58208
[69] Rizzo LY, et al. In vivo nanotoxicity
testing using the zebrafish embryo
assay. Journal of Materials Chemistry B.
2013;1(32):3918-3925
[70] Bai W et al. Toxicity of zinc oxide
nanoparticles to zebrafish embryo: A
physicochemical study of toxicity
mechanism. Journal of Nanoparticle
Research. 2010;12(5):1645-1654
[71] Browning LM et al. Silver
nanoparticles incite size- and dose-
dependent developmental phenotypes
and Nanotoxicity in Zebrafish embryos.
Chemical Research in Toxicology. 2013;
26(10):1503-1513
[72] Raies AB, Bajic VB. In silico
toxicology: Computational methods for
the prediction of chemical toxicity.
Wiley Interdisciplinary Reviews:
Computational Molecular Science. 2016;
6(2):147-172
[73] Fourches D, Pu D, Tropsha A.
Exploring quantitative nanostructure-
19
Challenges for Assessing Toxicity of Nanomaterials
DOI: http://dx.doi.org/10.5772/intechopen.89601
activity relationships (QNAR) modeling
as a tool for predicting biological effects
of manufactured nanoparticles.
Combinatorial Chemistry & High
Throughput Screening. 2011;14(3):
217-225
[74] Venkatapathy R, Wang NCY.
Developmental toxicity prediction. In:
Computational Toxicology. Springer;
2013. pp. 305-340
[75] Park M et al. Hazard evaluation in
GUIDEnano: A web-based guidance tool
for risk assessment and mitigation of
nano-enabled products. In: New Tools
and Approaches for Nanomaterial
Safety Assessment. Malaga, Spain:
DiVA; 2017
[76] Fadeel B et al. Advanced tools for
the safety assessment of
nanomaterials. Nature Nanotechnology.
2018;13(7):537
[77]Manke A, Wang L, Rojanasakul Y.
Mechanisms of nanoparticle-induced
oxidative stress and toxicity.
BioMed Research International. 2013;
2013:15
[78] Khalid P et al. Toxicology of carbon
nanotubes-a review. International
Journal of Applied Engineering
Research. 2016;11(1):148-157
[79] Li X, Lenhart JJ, Walker HW.
Aggregation kinetics and dissolution of
coated silver nanoparticles. Langmuir.
2011;28(2):1095-1104
[80] Kim I-Y et al. Toxicity of silica
nanoparticles depends on size, dose, and
cell type. Nanomedicine:
Nanotechnology, Biology and Medicine.
2015;11(6):1407-1416
[81]Hao N, Li L, Tang F. Roles of
particle size, shape and surface
chemistry of mesoporous silica
nanomaterials on biological systems.
International Materials Reviews. 2017;
62(2):57-77
[82] Bharadwaj VN et al. Temporal
assessment of nanoparticle
accumulation after experimental brain
injury: Effect of particle size. Scientific
Reports. 2016;6:29988
[83] Chen N et al. The cytotoxicity of
cadmium-based quantum dots.
Biomaterials. 2012;33(5):1238-1244
[84] Salatin S, Maleki Dizaj S, Yari
Khosroushahi A. Effect of the surface
modification, size, and shape on cellular
uptake of nanoparticles. Cell Biology
International. 2015;39(8):881-890
[85] Chithrani BD, Ghazani AA, Chan
WCW. Determining the size and shape
dependence of gold nanoparticle uptake
into mammalian cells. Nano Letters.
2006;6(4):662-668
[86]Maysinger D et al. Gold
nanourchins and celastrol reorganize the
nucleo-and cytoskeleton of glioblastoma
cells. Nanoscale. 2018;10(4):1716-1726
[87] Albanese A, Tang PS, Chan WC.
The effect of nanoparticle size, shape,
and surface chemistry on biological
systems. Annual Review of Biomedical
Engineering. 2012;14:1-16
[88] Pozzi D et al. Effect of
polyethyleneglycol (PEG) chain length
on the bio–nano-interactions between
PEGylated lipid nanoparticles and
biological fluids: From nanostructure to
uptake in cancer cells. Nanoscale. 2014;
6(5):2782-2792
[89] Stark WJ. Nanoparticles in
biological systems. Angewandte Chemie
International Edition. 2011;50(6):
1242-1258
[90] Richards D, Ivanisevic A. Inorganic
material coatings and their effect on
cytotoxicity. Chemical Society Reviews.
2012;41(6):2052-2060
[91] Karimi Z, Karimi L, Shokrollahi H.
Nano-magnetic particles used in
20
Biochemical Toxicology - Heavy Metals and Nanomaterials
biomedicine: Core and coating
materials. Materials Science and
Engineering: C. 2013;33(5):2465-2475
[92] Avcu E et al. Electrophoretic
deposition of chitosan-based composite
coatings for biomedical applications:
A review. Progress in Materials Science.
2019;103:69-108
[93]Worthington KL et al. Chitosan
coating of copper nanoparticles reduces
in vitro toxicity and increases
inflammation in the lung.
Nanotechnology. 2013;24(39):395101
[94] Shukla S et al. In vitro toxicity
assessment of chitosan oligosaccharide
coated iron oxide nanoparticles.
Toxicology Reports. 2015;2:27-39
[95] Yin H, Too H, Chow G. The effects
of particle size and surface coating on
the cytotoxicity of nickel ferrite.
Biomaterials. 2005;26(29):5818-5826
[96]Magrez A et al. Cellular toxicity of
carbon-based nanomaterials. Nano
Letters. 2006;6(6):1121-1125
[97] Bal-Price A, Meek MEB. Adverse
outcome pathways: Application to
enhance mechanistic understanding of
neurotoxicity. Pharmacology &
Therapeutics. 2017;179:84-95
[98] Saini B, Srivastava S. Nanotoxicity
prediction using computational
modelling - review and future
directions. IOP Conference Series:
Materials Science and Engineering.
2018;348:012005
[99]Qiu TA, Clement PL, Haynes CL.
Linking nanomaterial properties to
biological outcomes: Analytical
chemistry challenges in nanotoxicology
for the next decade. Chemical
Communications. 2018;54(91):
12787-12803
21
Challenges for Assessing Toxicity of Nanomaterials
DOI: http://dx.doi.org/10.5772/intechopen.89601
